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ORAL AND NASAL MUCOSAL PATHWAYS OF PRION INFECTION IN 
CHRONIC WASTING DISEASE 
 
 Chronic wasting disease (CWD) is a fatal neurodegenerative prion disease of 
deer, elk, and moose.  The unique feature of CWD as a prion disease is its efficient 
transmission among cervids in nature.  As with other prion infections, CWD disease 
inception relies on the conversion of the normal host cellular prion protein (PrP
C
) to the 
abnormal, protease-resistant isoform (PrP
CWD
)--the diagnostic hallmark of prion diseases.  
Since its detection in Colorado in 1967, CWD has spread to captive and free-ranging 
cervid species in 16 additional states, 3 Canadian provinces, and one Asian country.  
CWD is also exceptional as the only prion disease to afflict a free-ranging, wildlife 
population.  Understanding the facile means by which CWD is transmitted from animal 
to animal is important not only in understanding prion transmission overall but also in 
elucidating the potential public health consequences of cross species prion transmission.  
This dissertation work asks whether and how CWD prions are able to cross the oral and 
nasal mucosa to induce infection and disease.  
 The above questions were addressed through the use of two strains of transgenic 
mice that express the normal cervid prion protein [Tg(CerPrP)1536, Tg(CerPrP-
 iii 
E226)5037+/-] and prion protein knockout mice [FVB PrP
0/0
] exposed by either aerosol, 
nasal, or oral route to CWD prions.  In the first series of studies, cohorts of 
Tg(CerPrP)1536 mice were exposed to brain homogenates from either CWD-infected or 
CWD-naïve deer via either aerosolization or direct nasal installation.  In the second series 
of studies, cohorts of Tg(CerPrP-E226)5037+/- mice were exposed to the same inocula 
via installation onto the lingual mucosal surface which had or had not been previously 
subjected to superficial abrasions. Mice were then observed and tissues from each cohort, 
at time points ranging from weeks to as long as 2 years post inoculation, were examined 
for the presence of the abnormal prion protein of CWD (PrP
CWD
 ) using western blotting 
and immunohistochemistry assays. The final studies employed the same inoculation 
techniques used in the first two studies to seek to identify early (less than 4 hours) sites of 
prion entry via the mucous membranes. 
 The results of these dissertation studies demonstrated; 1) that CWD could be 
transmitted by aerosol exposure with high efficiency compared with direct inoculation 
onto the nasal mucosa; and 2) that micro-abrasions to the lingual surface greatly 
facilitated CWD prion transmission.  Finally and perhaps surprisingly, we were unable to 
detect PrP
CWD
 in either the nasal or oral mucosa shortly after inoculation or at any time, 
even after the onset of clinical symptoms of CWD.  The results from these studies 
suggest that; 1) CWD prions can be transmitted by aerosol exposure; thus exposure to the 
respiratory system merits increased consideration in prion transmission and biosafety; 2) 
minor oral mucosal injury does greatly facilitate prion infection—a potentially significant 
co-factor in CWD transmission of foraging cervids; and 3) these mucosal pathways may 
 iv 
explain how and why CWD is transmitted with high efficiency in animals exposed to low 
concentrations of prions in nature.   
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Prions and the ‘Protein-Only’ Hypothesis: 
The term ‘prion’ was coined by Dr. Stanley Prusiner in 1982 to describe the 
“proteinaceous infectious particles” thought to be the cause of transmissible spongiform 
encephalopathies (TSE’s) (97).  At the time, this statement was highly controversial as 
prion diseases had been considered slow-virus diseases (114) for nearly 40 years.  Yet the 
inception of the term was warranted given the following observations; 1) formalin and 
heat did not inactivate the scrapie agent (49); 2) high doses of ionizing and UV radiation 
also did little to inactivate the scrapie agent (3, 4); and 3) purified scrapie agent subjected 
to protease and electrophoretic studies indicated the infectious components were proteins 
that lacked nucleic acids (100, 101).  The culmination of the previous studies led Prusiner 
to postulate the ‘protein-only’ hypothesis (97) as an alternative to the virus theory.   
 
Prion Protein Structure and Function: 
 The normal host cellular prion protein (PrP
c
) is endogenous, expressed in all 
tissues with the highest concentrations within the central nervous system (CNS) (11, 17, 
37, 90).  PrP
c
 is approximately 250 amino acids in length, contains key motifs including a 
series of five peptide repeats and a central hydrophobic core, flanked by a carboxy-
terminal glycosylphosphatidylinositol (GPI) anchor and an amino-terminal signaling 





Fig. 1 Illustration representing the structural motifs of the prion protein               
 
within lipid rafts of cell membranes, the function of PrP
c
 is thought to be related to 
copper (Cu
2+
) binding, cell signaling, or adhesion (36).   
The entire principle of prion diseases resides on the recruitment and conversion of 
PrP
c
 to the disease or protease resistant protein form – PrP
res
 (103).  The mechanism 
behind the conversion process is still not fully understood.  Initially, structural 
modification experiments revealed the scrapie agent to be a protein (84, 100, 101).  Upon 




 were shown to be identical 
(9, 92) indicating post-translational modifications accounted for the structural 
differences.  While implications that cellular factors such as nucleic acids, lipids, 
proteoglycans, and proteins have been considered in assisting the conversion process, no 
chemically modifying features have been identified (1, 16, 25, 120).  Conversion was 
therefore believed to come about strictly through conformational change. 
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Evidence supporting this theory was revealed by the partially determined 




.  Results on both protein isoforms from Fourier-
transform infrared (FTIR) spectroscopy, circular dichroism (CD) spectroscopy, and 
electron microscopy (EM) analysis demonstrated PrP
c
 consists predominantly of α-
helical (~ 43%) content with a small β-sheet (~ 5%) [Fig. 2.I] while PrP
res
 is an enriched 
β-sheet (~ 40%) isoform with reduced α-helical (~ 30%) content [Fig. 2.II] (94, 105).  
This β-helix conformational shift renders the protein resistant to protease digestion (84) 




Fig. 2 Proposed partial structural representations of the cellular [PrP
c
] (I) and resistant  
          [PrP
res
] (II) prion protein.   
  
Two possible scenarios for conversion have emerged; 1) a template-assistance 
(refolding) model and; 2) a nucleation-polymerization (seeding) reaction.  The template-
I II
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 cannot occur due to 





 induces the conformational shift (102, 103).  Host cellular factor(s)/chaperone(s) are 
required for conversion (24, 26, 104).  Proposed structural intermediates (denoted PrP*) 
(28) formed by the interaction of PrP
c
 and unknown ‘protein X’ (123) are thought to 
lower the activation energy and facilitate conversion when bound to PrP
res
, yet no 




 are in 
thermodynamic equilibrium and when multiple PrP
res
 monomers assemble, a stable 
aggregate is formed (20).  Initial aggregate formation is slow, yet once established, 
allows for faster recruitment and conversion of additional monomers (20).  Whether 
aggregate formation within the central nervous system (CNS) is the root cause of the 
neuropathies associated with prion diseases remains unclear. 
  
Transmissible Spongiform Encephalopathies (TSE): 
While ‘priontology’ is a relatively new field in science, descriptive accounts of 
TSE’s (scrapie) trace back over 200 years.  In the late 50’s, Klatzo et. al. (72) and 
Hadlow (51) recognized the similarities in histopathology between scrapie, Kuru, and 
Creutzfeldt-Jakob disease.  The responsible agent was unaffected by filters designed to 
eliminate bacteria, therefore deemed a virus, and due to the long latency periods 
involved, these conditions were classified as ‘slow virus’ diseases (114).   
Prion diseases are neurodegenerative disorders that are invariably fatal in both 
humans and animals, with no evidence of a febrile or humoral immune response (45, 51, 
80).  Clinical disease in humans typically manifest as progressive dementia with 
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involuntary tremors whereas animals usually present with noticeable ataxia (129).  
Histopathologic characteristics for both species include spongiform changes and 
astrocytic gliosis (98), with the true hallmark of prion disease being the accumulation of 
PrP
RES
 in the brain (84).  Variations in clinical presentation and histological features exist 
in most prion diseases. 
Mammalian prion proteins are highly conserved within species; differences in 
amino acid sequences and host cellular factors appear to mediate the species barrier or 
susceptibility of disease transmission between species (22, 78, 102).  The existence of 
prion strains provides an additional explanation for disease variations seen within a 
species.  Prion strains have distinct biological characteristics which can be classified by 
incubation period (30), pattern of PrP
RES
 deposition (57), histopathology (39), and 
differences in behavior (96).  Biochemical characteristics, such as protease sensitivity and 
molecular weight differences after protease digestion can also be used in classifying prion 
strains (12).   
  
Creutzfeldt-Jakob Disease (CJD):     
 Creutzfeldt-Jakob disease was first described in the early 1920’s by Creutzfeldt 
and Jakob (76).  CJD can arise spontaneously (133), affecting ~1 in 1 million individuals 
worldwide (81).  Approximately 5 – 15% of diagnosed CJD cases are familial (18); i.e. 
associated with known mutations in the PRNP gene (60).  Familial Fatal Insomnia (FFI) 
(48) and Gerstmann-Straussler-Scheinker disease (GSS) (60) are two examples of 
inherited prion diseases, but as many as 16 different polymorphisms with upwards of 55 
pathogenic mutations have been identified (74).   In 1968, Gibbs et. al. (47) demonstrated 
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that CJD was transmissible.  Subsequent investigations revealed iatrogenic transmission 
of CJD occurred through corneal transplants (34), dura mater grafts (124), and hormone 
replacement therapy with human pituitary tissue (73).  While the infectious component 




Kuru is a prion disease of the Fore people of Papua New Guinea that primarily 
affected adult females and children of all ages, yet rarely adult males (44).  Experiments 
in chimpanzees demonstrated that Kuru was transmissible (43).  Natural disease 
transmission and familial patterns were explained by the practice of ritualistic 
cannibalism, where a mourning family, consisting only of women and children consumed 
the entire relative as a sign of respect (40).  With the cessation of cannibalism, the 
incidence rate has decreased to almost zero.  The origin of Kuru is not known yet one 
theory speculates that a sporadic case of CJD was responsible for the epidemic (42).  
 
Transmissible mink encephalopathy (TME): 
Outbreaks of transmissible mink encephalopathy in the United States and Europe 
are associated with the consumption of contaminated ovine or bovine feed (56, 79), 
although sporadic cases, albeit rare, do occur.  Transmission studies into several species 
using TME material from a single outbreak demonstrated the existence of multiple strains 
(80).  Expansive work from the previous study demonstrated the structure of PrP
RES
 is 
largely responsible for determining prion strains (12, 13).   
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Bovine Spongiform Encephalopathy (BSE):  
Bovine spongiform encephalopathy, or ‘mad cow’ disease, was first recognized in 
the United Kingdom in 1986 (129).  Evidence based on simultaneous countrywide 
outbreaks, the young age of affected animals, and method of calf rearing led investigators 
to the dietary supplement, meat and bone meal (MBM) as the potential source (131).  
Omission of organic solvents in the rendering process of MBM was thought to allow 
prion survival (131).  Initiation of a ruminant feed ban effectively decreased the incidence 
rate, supporting the idea that MBM contained the infectious agent.  During the epidemic, 
BSE transmission by contaminated MBM was confirmed in 43 exotic species (71) and 
the direct consumption of infected cattle caused variant CJD in humans (132).   
 
Variant Creutzfeldt-Jakob Disease (v-CJD): 
Variant CJD emerged in the mid 1990’s exhibiting marked differences compared 
to sporadic CJD, such as age of onset (29 vs. 66 years), duration of illness (14 vs. 4.5 
months), and behavior changes (132).  Comparative analysis of v-CJD and BSE 
deposition of PrP
RES
 were similar compared to other CJD forms (29).  Transmission of 
BSE to mice demonstrated neuropathology, deposition patterns of PrP
RES
, and incubation 
times were identical to v-CJD (21).  The delayed onset of v-CJD compared to the BSE 
epidemic saw the same initial increase in cases and has declined in accordance with the 
ruminant feed ban and decreased BSE cases.  Kuru, TME, BSE, and v-CJD are similar in 





Index case reports of scrapie date back to the early 1700’s.  Unlike the previous 
TSE’s that are artificially transmitted, scrapie is contagious (114), perpetuated by either 
vertical and/or horizontal transmission (31, 95).  Scrapie pathogenesis involves a 
lymphatic phase prior to CNS involvement (128).  Scrapie was never a public health 
concern until BSE emerged as an epizootic disease in Great Britain (129).  Even then, no 
causative links between scrapie outbreaks and CJD cases were found (18).  A major 
resurgence in the interest of prion diseases and the concern over the safety of human food 
came with the diagnosis of v-CJD (132).  Consequently, chronic wasting disease (CWD) 
has fallen under intense scrutiny by the demonstration of BSE transmission to humans.       
 
Chronic Wasting Disease: 
 Chronic wasting disease (CWD) is a TSE that affects mule and white-tailed deer 
(Odocoileus hemionus and virginianus), Rocky Mountain elk (Cervus elaphus nelsoni), 
and most recently moose (Alces alces shirasi) (6, 75, 106, 117, 137).  CWD was first 
described as a spongiform encephalopathy of captive Colorado mule deer in 1967 (134).  
Within a decade, sporadic cases of CWD were reported in free-ranging deer and captive 
elk populations in Northern Colorado and Southeastern Wyoming.  Shortly thereafter, 
Williams et. al. (136) intracranially (IC) inoculated infectious brain material into deer to 
establish that CWD was a TSE.  At present, CWD has been identified in 17 states, 3 
Canadian provinces, and the country of South Korea (33, 61, 68).  Prevalence rates in 
wild herds can vary from < 1% to over 30%, but can exceed 90% in captive herds (85, 
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86, 89, 130, 134, 137).  Interestingly, the cervid family is the only known free-ranging 
wildlife species affected by a TSE.  
 
CWD Clinical Presentation: 
Clinical presentation of CWD includes behavior changes (nervousness or hyper-
excitability), excessive salivation, polyuria/polydypsia, emaciation, poor coat quality, 
drooping head and ears, repetitive patterning, and ataxia (117, 135).  Gross pathology is 
noted as excessive fluid mixed with sand and gravel within the rumen along with a total 
loss of subcutaneous and abdominal adipose tissue (86, 117, 134).  Clinical symptoms 
can vary greatly among animals.  Manifestation of disease occurs in ages ranging from 18 
months to 10+ years (average between 3-5 years) with the duration of clinical disease 
lasting from 2 weeks up to almost 1 year (6, 75, 86, 106, 117, 135, 136).   
 
CWD Histological Features: 
Histological evidence of disease was initially characterized solely by gross 
examination of central nervous system (CNS) tissue, as non-neural tissues exhibited no 
discernible lesion profile (135, 136).  Gross lesions within the CNS include intraneuronal 
vacuolization, neuronal degeneration, and spongiosis of the grey matter, accompanied by 
a reactive gliosis, astrocytic hypertrophy and hyperplasia, and the presence of 
eosinophilic amyloid plagues (134-137).  The extent of disease dissemination was greatly 
expanded upon by the discovery that the scrapie fibril antibody used in immunohisto-




 An essential technique in diagnosing CWD by immunochemical means requires 
pre-treatment of test samples with proteinase K (PK) to eliminate cellular prion proteins 
(PrP
C
), leaving the protease resistant core (PrP
CWD
) which is detected with prion 
antibodies.  Current diagnostic methods include conventional immunohistochemistry 
(IHC) for post-mortem analysis of obex and retropharyngeal lymph nodes and/or ante-
mortem analysis of tonsil and rectal lymphoid tissue biopsies (116, 117, 130) and a 
United States Department of Agriculture (USDA) approved enzyme-linked 
immunosorbent assay (ELISA) for tissue analysis (59).  An additional laboratory method 




 is the standard western blot (WB).  This 
assay demonstrates in uninfected material the absence or presence of PrP
C
 in PK vs. non-
PK treated samples (respectively), whereas the molecular weight difference of the 
truncated PrP
CWD
 protein of infected material is shown in PK vs. non-PK treated samples, 
respectively.   
 
CWD Pathogenesis: 
With the advent of an immunological marker to detect PrP
CWD
 aggregates, studies 
were undertaken to investigate the pathogenesis of CWD.  Initial experiments confirmed 
the presence of PrP
CWD
 aggregates within the retropharyngeal lymph node (RLN) , 
tonsils, and Peyer’s patch of orally inoculated deer (113) and in the CNS of terminal, 
naturally exposed deer (117).   These findings concurred with scrapie studies which had 
shown equivalent early accumulation and terminal patterns of PrP
Sc
 after oral 
inoculations and naturally occurring disease, respectively (5, 52, 58).  Complete tissue 
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analysis of free-ranging and captive, naturally infected animals confirmed that the CNS 
and lymphatic tissues contained the highest concentration of CWD infectivity (77, 118, 
119), with the observation that oropharyngeal and gut associated lymphoid tissue 
(GALT) infections appeared] to precede CNS involvement.  Subsequent study of 
naturally occurring and oral inoculation cases reaffirmed that lymphoid tissues were the 
primary sites of PrP
CWD
 accumulation (38, 75, 115, 130).  Involvement of the myenteric 
plexus, vasosympathetic trunk, and nodose ganglion (10, 112) provided evidence for 
theoretical, internal trafficking routes from the enteric nervous system to the CNS, yet no 
definitive mechanism for initial uptake has been elucidated.    
 
CWD Transmission: 
While the trafficking of prions from lymphatic sites to the CNS is becoming well 
defined, the question of how prions are naturally acquired remains unknown.  CWD is 
thought to be transmitted horizontally, as current evidence does not support vertical 
transmission (87-89).  Bodily fluids and excreta, including urine, feces, saliva, and blood 
have all been shown to contain infectious CWD prions, albeit small quantities (53, 67, 83, 
122).  Assumptions that CWD can be transmitted through direct contact during social 
interactions have been made; however studies demonstrated that indirect mechanisms 
(animals housed on previously contaminated pastures, fomite transmission) proved highly 
effective (82, 88).  While prion amounts excreted into the environment are minimal, 
confounding evidence related to prion – soil interactions, persistence, and infectivity 
suggests soil as a significant reservoir for scrapie and CWD infectivity.   
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Scrapie prions bind to soil particles with high affinity (66), possibly enhancing 
initial infectivity (65), and remain infectious for 3 years under experimental conditions 
(19, 110) with suggested environmental persistence of at least 16 years (46).  
Environmental contamination could therefore play a large role in disease transmission as 
soil consumption is part of natural cervid behavior (15, 63).  In any case, exposure and 
entry of CWD prions through the oral and/or nasal mucosa seems assured.   
Cervids have a highly-developed olfactory epithelium which is used to monitor 
their environment for food, predators, prey, and pheromones (reproductive cues) (35, 
125).  The Flehmen response is used in particular to draw in pheromones and other 
aerosolized and solid compounds into the vomeronasal organ (VNO), which is a 
specialized neurosensory organ in the anterior nasal mucosa (32).  Aside from detecting 
environmental odors, respiratory epithelium can be exposed to disease causing agents 
through normal respiration.   
Studies have demonstrated that cervids are highly susceptible to Mycobacterium 
bovis and foot-and-mouth disease via aerosol transmission (2, 27, 93).  In 1995, Shaw 
(111) suggested the occurrence of shortened incubation periods for CJD in farmers could 
have come from “breathing the dust from feed containing prions.”  While this theory was 
never investigated, subsequent studies employing scrapie and TME prions demonstrated 
intranasal inoculations were effective, and surprisingly more efficient than Per os (oral) 
inoculations (14, 55, 70, 107).  It is therefore reasonable that the nasal passages of cervids 
are likely exposed to CWD prions when performing the Flehmen response and social 
nuzzling.   
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  Prior to the studies contained in this dissertation, no information pertaining to 
the potential risk posed by aerosolized prions or the exposure of the nasal mucosa to 
CWD prions existed.  Demonstrating aerosol transmission of CWD prions could warrant 
the re-evaluation of respiratory system exposure in prion disease transmission.  
Additionally, re-evaluation of biosafety protocols might be required depending on the 
potential risk.  Current CDC recommendations are that human and animal prions should 
be manipulated at biosafety level (BSL)-2, with certain BSE-human circumstances in 
which splashes and/or aerosolized infectious material could be created requiring 
additional physical containment or BSL-3 (62).  
Oral prion inoculation studies have been conducted in attempt to mimic a more 
natural route of infection.  Consistent outcomes in these experiments, when compared to 
the conventional intracranial inoculations, were that a substantially larger inoculum dose 
was required, incubation times were longer, and disease transmission was less efficient 
(54, 69, 99, 109, 113, 126).  These studies were also problematic in that brain tissue, most 
likely an atypical source of shed prions in nature, was used as the inoculum.  When 
infectious excreta were administered orally, saliva was sufficient to initiate clinical 
disease whereas urine and feces produce an asymptomatic disease that was not detectable 
by conventional means (53, 83).   These findings suggest that the amount of infectious 
prions were substantially less in urine and feces and that longer incubation times are 
likely required to establish an infection.   
CWD is most assuredly transmitted through the oral route, yet the amount of 
infectious material in excreta indicates that animals would either have to ingest a single, 
massive quantity, be exposed for an extended amount of time, or perhaps be exposed at 
 14 
some permissive mucosal portal or site.  The latter situation implies that prions require 
assisted entry.  A possible co-factor, such as an abraded mucosal surface might play a 
role in facilitating transmission.  In 1985, Gajdusek (41) speculated that Kuru could be 
passed to conjunctiva by eye rubbing, nose picking, or through mucosal injury.  A study 
in mice (23) and hamsters (64) demonstrated that infection by the scrapie agent was 
enhanced if the inoculum was applied to scarified gingival tissue.  Subsequent studies 
demonstrated that inoculation of TME or scrapie agent onto abrasions on the tongue or by 
intra-lingual injection produced up to a 100,000-fold more efficient transmission rate than 
standard oral inoculation (7, 8, 14, 54, 91).   The above studies were seminal for this 
dissertation research on the transmission of CWD. 
   
Questions addressed in this dissertation: 
1.) Can CWD prions be transmitted in an aerosolized form? 
2.) Are the nasal passages a viable route for initiating CWD infection? 
3.) Do lingual abrasions facilitate the transmission of CWD? 
4.) Can the site(s) of CWD prion entry in the oral and/or nasal mucosa be 
discerned shortly after inoculation?    
 
Dissertation Research: 
 The background of TSE research provided the basis for the specific aims of this 
dissertation research.  The first objective was to determine whether CWD prions could be 
transmitted via exposure of the nasal mucosa and/or VNO.  Our goal was to investigate 
pathways whereby CWD prions are passed efficiently from one animal to the next.  This 
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objective was addressed by using transgenic mice that express the normal cervid prion 
protein [Tg(CerPrP)1536] exposed by either aerosolized particles or direct nasal 
instillation and assessed for disease by clinical presentation and detection of PrP
CWD
 by 
western blotting and immunohistochemistry assays. 
 The second objective was to determine whether CWD prions could be transmitted 
via exposure of the intact or disturbed oral mucosa.  Our hypothesis was that the transit of 
CWD prions across the alimentary tract mucosa would be substantially enhanced by 
minor abrasions to the oral mucosa—a phenomenon especially pertinent to cervids that 
commonly subsist on abrasive forage.  Our rationale in the studies conducted was to 
determine whether lingual abrasions lead to shorter incubation periods, thereby providing 
insight into one mechanism for the facile transmission of CWD under natural conditions.  
We addressed this objective by again using cervidized transgenic mice [Tg(CerPrP-
E226)5037+/-] exposed to CWD by a single inoculation to the surface of the tongue in 
mice that had or had not received superficial mucosal abrasions.  We then monitored and 
assessed these animal cohorts for CWD infection by clinical criteria and examination for 
PrP
CWD
 in tissues by western blotting and immunohistochemistry assays.  
 The third objective was to determine the early tissue site(s) of CWD prion transit 
across the mucosal surface after inoculation.  We hypothesized that; 1) PrP
CWD
 could be 
detected in the olfactory epithelium, stimulated VNO, or NALT after respiratory 
exposure; and 2) PrP
CWD
 could be detected at the abrasion site of the lingual mucosa after 
oral exposure.  Our goal was to determine the cellular association of PrP
CWD
 in the 
respective mucosa immediately or within hours after inoculation in order to elucidate the 
mechanism(s) behind early pathogenesis.  We addressed this objective through the use of 
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cervid, prion protein expressing transgenic mice [Tg(CerPrP)1536, Tg(CerPrP-
E226)5037+/-] and a prion protein knockout mouse [FVBPrP
0/0
] exposed by aerosol, 
nasal, or oral routes.  Serial sacrifices were performed within hours and tissues were 
assessed by the tyramide signal amplification immunohistochemistry assay in attempt to 
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ABSTRACT 
 
Little is known regarding the potential risk posed by aerosolized prions.  Chronic 
wasting disease (CWD) is transmitted horizontally, almost surely by mucosal exposure, 
and CWD prions are present in saliva and urine of infected animals.  However, whether 
CWD may be transmissible by the aerosol or nasal route is not known.  To address this 
question, FVB mice transgenetically expressing the normal cervid PrP
C
 protein 
[Tg(cerPrP) mice] were exposed to CWD prions by either nose-only aerosol exposure or 
by drop-wise instillation into the nostrils.  Mice were monitored for signs of disease for 
up to 755 days post inoculation (dpi) and by examination of tissues for lesions and 
PrP
CWD
 after necropsy.  In particular, nasal mucosa, vomeronasal organ, lungs, lymphoid 
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tissue, and the brain were assessed for PrP
CWD
 by western blotting and 
immunohistochemistry.  Six of 7 aerosol-exposed Tg(cerPrP) mice developed clinical 
signs of neurologic dysfunction mandating euthanasia between 411 and 749 dpi.  In all 
these mice, CWD infection was confirmed by detection of spongiform lesions and 
PrP
CWD
 in the brain.  Two of 9 intra-nasally inoculated Tg(cerPrP) mice also developed 
TSE associated with PrP
CWD
 between 417 and 755 dpi.   No evidence of PrP
CWD
 was 
detected in CWD-inoculated Tg(cerPrP) mice examined at pre-terminal time points.  
These results demonstrate that CWD can be transmitted by aerosol (as well as nasal) 
exposure and suggest that exposure via the respiratory system merits consideration for 




Chronic wasting disease (CWD) is an efficiently transmitted prion disease 
[transmissible spongiform encephalopathy (TSE)] affecting deer, elk, and moose.  
Although discovered in northern Colorado and southern Wyoming, CWD has since been 
identified in 13 additional states, 3 Canadian providences and Korea (7, 15, 20).  CWD is 
unique as the only TSE that occurs in wild animal populations.   
Available information indicates that CWD is transmitted by some horizontal 
means, most likely involving trans-mucosal entry (26, 30, 38).  CWD prions are known to 
be present in saliva and urine of infected cervids (10, 24) and excreted prions can 
contaminate the environment and persist for years, given that clay components of soil 
bind prion proteins with high affinity (16).  Exposure of the nasal or other respiratory 
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mucosa via aerosolization or direct contact to CWD prions is sufficient to initiate 
infection and disease remains unproven, yet plausible.  Precedent for nasal transmission 
of prion disease can be found in studies of experimental scrapie in sheep and mice and 
transmissible mink encephalopathy (TME) in hamsters (11, 21, 28). 
Olfactory sensory nerve endings in the olfactory epithelium (4) of animals such as 
cervids are highly-developed to monitor the environment, e.g. to locate food, predators 
and prey, and detect the pheromones initiating reproductive behaviors (8, 36).  
Reproductive cues in particular are detected by the Flehmen response which draws the 
trapped particulates into the vomeronasal organ (VNO), a specialized neurosensory 
region in the anterior nasal mucosa (6).  The Flehmen response and social nuzzling both 
provide opportunities for CWD prions to enter the nasal passages.   
To determine directly whether CWD is transmissible by the respiratory route, 
cervid PrP-expressing transgenic mice (Tg(CerPrP) mice) were exposed to CWD prions 
by aerosolization or intranasal instillation.  We present evidence that exposure of the 
respiratory mucosa to CWD prions is sufficient to transmit the disease after long 
incubation periods. 
 
MATERIAL AND METHODS 
 
Tg(CerPrP) Mice: 
 The cervid PrP-expressing transgenic mice and their susceptibility to CWD 
infection after intracerebral inoculation have been described previously (3).  All mice 
were cared for in accordance with Colorado State University ACUC guidelines.  
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Confirmation of the cervid PrP
C
 gene insert was performed by western blot and PCR.  
The Tg(cerPrP) mice were 5 to 12 weeks of age at inoculation.  After inoculation, mice 
were examined for evidence of neurologic abnormality every 2 days and weighed weekly 
(starting at 3 months post inoculation).  Criteria for assessing CWD symptoms included 
ataxia, lethargy, tail rigidity, poor coat quality, and weight loss.  Once the onset of 
clinical signs was observed, mice were isolated into individual cages to prevent 
cannibalism from cage mates.  Mice were euthanized when distinct signs of neurologic 
disease were evident, accompanied by an age-matched sham control.  CWD and sham-
inoculated mice were housed in separate rooms to minimize potential for cross 
contamination.    
 
Inocula and Inoculation Routes:  
The CWD inoculum consisted of brain homogenate from CWD-infected mule 
deer (D10), obtained through the courtesy of Dr. Michael Miller, Colorado Division of 
Wildlife.  CWD-negative (sham) control brain homogenate was from a CWD-naive 
white-tailed deer brain (UGA) obtained through the courtesy of Drs. David Osborn, Carl 
Miller, and Robert Warren at the University of Georgia Warnell School of Forestry.  
Brain homogenates were prepared in 1X phosphate-buffered saline (PBS) to a final 
concentration of 10% (w/v) for intranasal, 5% (w/v) for aerosol and 1% for intracerebral 
(IC) and per os (PO) inoculations.  All mice (except IC and PO) were administered a 0.01 
mL of epinephrine intraperitoneally, immediately post inoculation to stimulate the 
Flehmen response.  
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In two separate experiments, two cohorts of Tg(CerPrP) mice (n=6 CWD and n=6 
sham) were inoculated by exposure to an aerosol of 5% (w/v) CWD brain homogenate 
for 4-minutes in a custom designed chamber providing nose-only exposure.  The mice 
were monitored until clinical symptoms were detected or until study termination at 749 
days.  Two additional cohorts of Tg(CerPrP) mice (n=24 CWD and n=24 sham) were 
inoculated with 10 µL (5 µL per nostril) of the 10% weight to volume (w/v) extracts by 
direct pipet instillation into the nasal passages.  A total of 12 mice in each cohort 
(n=4/time point) were sacrificed at 7, 14 and 28 days post inoculation (dpi) and analyzed 
for early PrP
cwd
 detection.  The remaining mice (12/cohort) were monitored either until 
clinical symptoms became apparent or to study termination at 755 days.  Per os 
inoculations into Tg(CerPrP) mice were administered in 2-50µl doses of a 1% extract 
given on 2 consecutive days.  Intracerebral inoculations into Tg(CerPrP) mice of 30µl of 
a 1% extract from the same positive mule deer (D10) or naïve white tailed deer (UGA) 
served as positive and negative controls.   
 
Aerosolizing Chamber:  
Aerosolizing chambers commonly expose the entire animal to the agent being 
investigated.  Our goal to expose only the nose/nasal passages to CWD prions vs. the 
entire animal.  Thus we (NDD/JHK) fashioned an exposure chamber using a 473 ml, 
rubber-sealed lid container (Rubbermaid) into which 4 – 1” diameter holes were drilled 
into the side walls.  Four, 50 ml conical tubes (BD) with the tips removed were inserted 
and sealed into the holes.  Each tube was supported by an additional tube that collectively 
functioned as legs.  A 3/4” x 1/2” hole was also cut into the container to accommodate 
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the mouth of the Omron Nebulizer (NE-C21, J. H. Inc.).  The conical tubes and the 
nebulizer were sealed in place with silicone adhesive (GOOP).  Finally, a 0.22 µm filter 
unit (Sterivex™, Millipore) was attached and sealed to the lid of the container to serve as 
an air vent and trap aerosolized particles (Fig. 4a).  Once the mice and the inocula were 
loaded into the apparatus (Fig. 4b), the entire chamber was placed in a secondary  
enclosure and exposure occurred in a separately vented room. 
 
Fig. 4a. Aerosolizing chamber with nebulizer chamber and four plastic enclosures 
to accommodate anesthetized Tg(CerPrP) mice. 
 
Fig. 4b. Top view of aerosol chamber with lid removed showing Tg(CerPrP) mice 
inserted in place to provide nose-only exposure to the chamber (arrow). 
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Statistical Analysis:  
Statistics (Fisher Exact test) were performed using the software package 
Graphpad Prism™ 4. 
 
Delivered Dose Estimations:  
To approximate the total solid mass of brain inoculum deposited onto the mucous 
membranes of each aerosol-exposed mouse, we used a lognormal distribution generator 
program created by Dr. J. Volckens (Department of Environmental and Radiological 
Health Sciences, Colorado State University), using modified equations (14) for 
aerosolized particles.  Using particle sizes generated by the nebulizer of 0.1 to 10 µm (log 
distribution), the estimated number of particles per each size generated and a designated 
mass for each particle size, the total mass for each particle size was calculated.  The total 
mass was then multiplied by a deposition fraction (percentage of particles deposited in 
the respiratory tract based on size) and the fraction of total air inhaled by each mouse 
(1.2%; [(mouse respiration rate (163) multiplied by tidal volume (.00015 L)) / air flow 
through the system (2 lpm)]) to give the total deposited particle mass.  Using a 5% brain 
homogenate, with brain material containing approximately 10% solid material, we 
calculated the mass fraction of solids per particle to be 0.005g (0.05 x 0.10).  This 
fraction multiplied by the total deposited particle mass for each particle size produced the 
total mass of solid material deposited.  The sums from each particle size deposited mass 
where then added to generate the total amount of solid inocula deposited into each 
mouse.   
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Similar algorithms were used to estimate the total amount of solid inoculum 
deposited into each intranasally inoculated mouse based on 10 µL of a 10% brain 
homogenate.   
 
Western Blotting:  
Harvested tissues were prepared at 10% (w/v) in a 1X PBS/1% Triton-X 100 
mixture.  Glass beads (2.5mm, Biospec) were added to each tube and samples subjected 
to one Fastprep™ (Biosalvant) cycle for 45 seconds at a speed setting of 5.5, followed by 
a 2 minute cool down at -20º.  Samples were then centrifuged for 5 minutes at 2000 rpm 
to remove tissue debris and supernatants stored at -20º until further use.   
Samples were incubated with 50 mg/µL of Proteinase K (Invitrogen) for 30 
minutes at 37º, shaking at 1000 rpm.  Samples were then combined with a reducing 
agent/sample buffer (Invitrogen) to a final concentration of 1X and run through NuPage 
10% Bis-Tris gels (Invitrogen) for 2.5 hours at 100 volts.  Proteins were then transferred 
to 0.22µm PVDF membranes (Millipore) over 1.5 hours at a setting of 110 volts.  
Membranes were blocked in a casein/TBS (Thermo Scientific) + 0.2% Tween-20 mixture 
for 45 minutes, shaking at room temperature.  Monoclonal antibody BAR-224 (Spi-Bio) 
conjugated with HRP was used to detect the PrP
CWD
 (1:20,000 dilution in casein/TBS 
+0.2% Tween- 20).  Membranes were washed 3 times and developed with ECL Plus 
Western Blotting Detection kit (GE).  Blots were viewed and photographed with a Gel 





Tissues were fixed in 10% formalin for 5 days, transferred to 60% ethanol (with 
the exception of the nasal passages), embedded in paraffin, and sectioned at 5µm for 
staining.  Nasal tissues were placed in a 10% tetra-sodium EDTA (Sigma) solution for 10 
days, with a fresh solution change occurring on the fifth day. Slides were de-paraffined 
through a series of xylene/ethanol baths, treated in 89% formic acid for 30 minutes, 
rinsed in running water for 5 minutes, and then subjected to a 15 minute, antigen-retrieval 
process (Pickcell Laboratories, Netherlands).  The Dako Autostainer was used for 
conventional immunohistochemistry.  Briefly, slides were blocked with 3% H2O2 in 
methanol (30 minutes), blocked with TNB buffer (30 minutes), incubated with a 1:250 
dilution of HRP-conjugated BAR-224 in TNB (45 minutes), developed with chromagen 
AEC [3-Amino-9-Ethylcarbazole, Dako] (10 minutes), and counterstained with 
hematoxylin (5 minutes) and bluing reagent (1 minute).   Both H&E and IHC sections 
were evaluated for the presence of TSE lesions which were characterized by neuronal 




Intracerebral (IC) exposure:   
All IC inoculated mice exhibited clinical symptoms of CWD at 168 +/- 4 days 
post inoculation (dpi) and were euthanized.  PrP
CWD
 was detected in all positive controls 
by western blot (WB) and immunohistochemistry (IHC), thus confirming the infectivity 




  In our first aerosol exposure of Tg(cerPrP) mice, 4 of 6 CWD and 3 of 6 sham- 
exposed mice died within 0 to 6 days post inoculation.  The cause of death was not 
determined with certainty. After modification to the exposure protocol no similar 
fatalities occurred.  Of a total of the 7 mice exposed to CWD by aerosol, 6 developed 
TSE between 411 and 749 dpi.  None of the sham-inoculated mice developed evidence of 
prion infection through 749 dpi of observation.  Neurological signs, survival times, 
weight loss, and development of TSE lesions (primarily neuronal loss/vacuolation and 




Table 1  Aerosol Transmission of CWD in Tg(cerPrP) mice 
 




Weight loss  











Sham n=5 - 411-749 2 (average) - - - 
384 + 411 31 + + + 
746 + 417 32 + + + 
739 + 457 35 - - - 
732 + 524 27 + + + 
734 + 563 31 + + + 
738 - 708 11 - + - 
380 + 749 12 + + + 
 
* One sham control was sacrificed when a positive mouse was euthanized (if possible) 
† Animals were considered positive if they exhibited at least 3 of the following 






































Fig. 1  Kaplan-Meier survival plot of Tg(CerPrP) mice exposed to CWD by aerosol (○, 
black dotted line) vs. intranasal instillation (●, black solid line). 
 
Western blot and immunohistochemistry analysis of brains from the 7 CWD-
aerosol-exposed mice demonstrated PrP
CWD
 in 6 (Fig. 2a & 3a).  All of the mice exposed 
by aerosol to CWD-negative control deer brain inoculum were negative for PrP
CWD
 by 
WB (Fig. 2a; lane 1 & 2) and IHC (Fig. 3b).  Immunohistochemistry of the nasal 
passages, including the VNO, olfactory and respiratory epithelium, and nasal-associated 
lymphoid tissue (NALT), as well as the olfactory bulb of the brain and spleen, did not 
reveal PrP
CWD





 (lanes 3, 4, 6, 7, & 9) in brains of Tg(CerPrP) mice exposed to aerosolized 
CWD prions demonstrated by western blot.  Aerosolized sham control (lane 1 & 2) showing 
no PrP
CWD




 (lanes 4 & 6) in brains of Tg(CerPrP) mice exposed to CWD prions intra-
nasally demonstrated by western blot.  Intra-nasal sham control (lane 1 & 2) showing no 
PrP
CWD
.    
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Fig. 3. Immunohistochemistry (IHC) from the obex region of the medulla from 
Tg(CerPrP) mice (20X).  (a) PrP
CWD
 (arrows) in a mouse exposed to CWD by aerosol vs. 
(b) mouse exposed to sham inoculum.  (c) Mouse exposed to CWD by intranasal route 
demonstrating PrP
CWD





Intranasal (IN) exposure: 
Nine of 12 Tg(cerPrP) mice exposed to CWD by intra-nasal (IN) inoculation 
survived past 250 dpi.  Two of these 9 mice developed TSE at 422 and 498 dpi, 
respectively.  A summary of neurological signs, survival times, weight loss, and 
development of TSE lesions (primarily neuronal loss/vacuolation and gliosis) is in Table 
2 and Fig. 1.   
 
Table 2  Intranasal Transmission of CWD in Tg(cerPrP) mice 
 




Weight loss  











Sham n=9 - 361-755 5 (average) - - - 
635 + 361 39 - - - 
641 + 422 43 + + + 
646 + 443 50 - - - 
631 + 498 17 + + + 
633 - 551 +14 - - - 
630 - 755 23 - - - 
632 - 755 15 - - - 
645 - 755 19 - - - 
648 - 755 35 - - - 
 
* One sham control was sacrificed when a positive mouse was euthanized  
† Animals were considered positive if they exhibited at least 3 of the following 
symptoms: Ataxia, lethargy, tremors, weight loss, poor coat quality, rigid tail 
 
 
Both IN-inoculated mice that developed TSE had PrP
CWD
 accumulation in the 
brain, as detected by WB (Fig. 2b; lane 4 & 6) and IHC (Fig. 3c).  None of the mice 
exposed IN to CWD-negative control deer brain inoculum displayed clinical signs of 
CWD.  All were negative for PrP
CWD
 by WB (Fig. 2b; lane 1 & 2) and IHC (Fig. 3d).  In 
none of the negative control or CWD-inoculated mice sacrificed at planned time points or 
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dying spontaneously was evidence of PrP
CWD 
or histopathologic lesions of TSE detected 
(data not shown).  PrP
CWD
 was also not detected in the nasal passages, olfactory bulb, or 
spleen of any mice (data not shown).   
  
Statistical Analysis: 
Using Fisher’s Exact test demonstrated the attack rates in Tg(CerPrP) mice 
exposed to CWD by aerosol vs. nasal inoculation were significantly different (Fisher’s 
Exact test, p value = 0.0406). 
 
Dose Estimations: 
To estimate the quantity of brain material delivered per mouse by aerosol 
exposure, we used a lognormal distribution generator assumptions and calculations as 
described in Methods.  Based on particle sizes ranging from 0.1 to 10µm (log 
distribution) generated by the nebulizer we estimated that 24 µg of solid brain material 
was deposited on the mucous membranes of each mouse.  Applying the same algorithm 





In 1995, Shaw (29) suggested that the occurrence of a shorter incubation period 
for Creutzfeldt-Jacob disease in farmers could have come from “breathing the dust from 
feed containing prion”.  The present studies were done to simulate the inhalation of 
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airborne particles and the direct contamination of the nasal passages with CWD prions. 
The finding that CWD prions can be transmitted via inhalation (perhaps even more 
effectively than by nostril contact only) while unique for CWD infection, extends 
precedent for transmission of prions via the respiratory system.  Sheep and hamsters 
inoculated with scrapie intra-nasally (11, 28) and hamsters inoculated with TME extra-
nasally (21) have been shown to develop TSE.  Results in the latter study suggested that 
the nasal passages may even be more effective than the oral route in transmitting prion 
disease (21).   
In the present study, 86% (6/7) of Tg(cerPrP) mice exposed to CWD via aerosol 
developed CWD vs. 22% (2/9) of IN-exposed mice (Fisher’s Exact test, p value = 
0.0406).  It may be argued that the early deaths of 4 mice in the initial CWD-aerosol 
exposure group could bias the statistical significance of the results.  After modifications 
to the exposure procedure, early mortalities were eliminated.  Moreover, 2 of 2 surviving 
mice in the initial exposure and 4 of 5 mice in the second exposure study developed TSE.  
One possible explanation for the enhanced infectivity after aerosol exposure 
might be the disruption and dispersion of infectious PrP
CWD
 aggregates during 
aerosolization to yield more small infectious particles or seeds (31).  These smaller 
aggregates might be more readily taken up by lymphoid or distal airway epithelial cells 
not typically accessible by either nasal contact or drop-wise instillation of prions.   
Another potential explanation for enhanced infection after aerosolization could be 
that a larger prion dosage was delivered by aerosol vs. nasal exposure.  Based on a 
random distribution of infectivity in the aerosol material, the respiratory tidal volume of 
mice and the average anesthetized respiratory rate for a 4 min period, we calculated that 
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aerosol-exposed mice would receive approximately 1.2% of the available inoculum, or a 
maximum of 24µg of particulate inoculum deposited in the respiratory system.  Mice 
inoculated intra-nasally received 10µl of a 10% brain homogenate, or 100µg of 
particulate inoculum--4 times that delivered by aerosol.  Given that only the nostril region 
(< 5mm) of each mouse was exposed during aerosolization, we estimate that even if up to 
an additional 15µl of inoculum were to be ingested due to nasal region grooming, the 
total dosage would not surpass (and more likely would never attain) that delivered intra-
nasally.  
Clearly inoculation by either the aerosol or nasal route would result in inoculum 
entering the alimentary tract via the nasopharynx.  Thus oral exposure and potential 
uptake cannot be avoided or excluded.  However, oral inoculation of Tg(cerPrP) mice 
with 100µg CWD particulate brain homogenate failed to transmit CWD infection or 
disease after > 700 days of observation (Seelig, DM, Mason, GL, Telling, GC, Hoover, 
EA, unpublished results)(Table 3).  Thus it is unlikely that CWD transmission by the 
aerosol or nasal routes reflects infection via the alimentary tract.  
 
Table 3  Summary of CWD Inoculation Results in Tg(cerPrP) mice 
 
Route Exposure Dose Attack Rate* 
Aerosol 24µg † 6/7 (86%) 
Intranasal 100µg ‡ 2/9 (22%) 
Oral 100µg § 0/10 (0%) 
 
*No. affected/total (% positive) 
† 4 min aerosol of 5% w/v homogenate 
‡ 10µl of 10% w/v homogenate 
§ 100µl of 1% w/v homogenate 
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Mice are an excellent model for studying airborne and direct nasal contact 
transmissions because they are obligate nasal breathers (22).  Odorants and particles 
inhaled into the nasal passage are subject to a number of cell surfaces.  Thus multiple 
sites of CWD prion entry are plausible, including the nasal-associated lymphoid tissue 
(NALT), the mucosal associated macrophages and/or dendritic cells, respiratory 
epithelium, olfactory epithelium, and vomeronasal organ (VNO).  The NALT typically 
incorporates the retropharyngeal lymph nodes, palatine, and lingual tonsil (23) and is 
similar in structure and function to the gut-associated lymphoid tissue (GALT) in that it is 
responsible for antigen uptake and presentation by M cells, B cells, and follicular 
dentritic cells (13, 23).  The GALT, especially the Peyers patches are considered to be the 
primary site of PrP
Sc
 uptake for BSE, vCJD, and scrapie (1, 9, 12, 27, 35, 37).  
Mice do not have tonsils or retropharyngeal lymph nodes per se, but rather a bi-
symmetrical NALT structure that lines the floor of the nasal cavity (13).  Kinkaid and 
Bartz (21) found that hamsters inoculated via uptake of droplets or TME inoculum via the 
external nares had shorter incubation periods using lower dose of infectious prions than 
those inoculated orally.  Studies in deer inoculated orally or naturally exposed to CWD 
indicate that the primary structures that accumulate PrP
CWD
 early in infection are the 
retropharyngeal lymph nodes and tonsils (18, 30, 32).  Nevertheless, in the present study 
we were unable to demonstrate PrP
CWD
 in the NALT of early, pre-terminal, or terminal 
Tg(cerPrP) mice after aerosol or nasal exposure to CWD. 
 Another seemingly likely site for prion entry and infection is the olfactory 
mucosal epithelium, which contains odor receptors that provide a direct neural 
connection from the nasal cavity to the olfactory bulbs of the brain.  Previous 
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immunohistochemistry studies of deer terminally infected with CWD have demonstrated 
PrP
CWD
 depositions in the olfactory bulbs, which also show marked spongiform 
degenerative changes (33, 35, 39, 40).  However in deer, sequential PrP
CWD
 accumulation 
in the brain appears to occur in a caudal (brainstem) to rostral (frontal cortex) fashion as 
the disease progresses (34).  In the present study, PrP
CWD
 was not detected in the 
olfactory bulbs of terminal CWD-infected Tg(cerPrP) mice, although aggregates were 
identified in the frontal cortex immediately dorsal to the olfactory bulbs in some mice.  
This was especially surprising since the olfactory bulb glomeruli are sites of substantial 
cervid PrP
C
 expression in naïve Tg(cerPrP) mice. 
Given that CWD prions have been demonstrated in saliva (24), urine (10, 17) and 
soil (16), it is possible that prion entry could involve the vomeronasal organ (VNO)--a 
region of the anterior ventral nasal passages specialized to detect non-volatile molecules 
such as pheromones by a process known as the Flehmen response (36);(19); (25).  
Nevertheless, neither we nor DeJoia (5) were able to detect PrP
RES 
in the VNO of 
terminal CWD-inoculated Tg(cerPrP) mice or TME-inoculated hamsters, respectively.  
Thus while all of the above exposure studies failed to identify PrP
CWD/RES
 in mucosal 
sites, it remains likely that early prion trafficking involves relatively few potentially 
protease-sensitive oligomeric molecules which may not be identifiable with the detection 
methods used. 
Our inability to detect PrP
CWD
 outside the central nervous system (CNS) in the 
present studies was somewhat perplexing.  This finding could reflect a more limited 
peripheral expression of PrP
C 
expression in the Tg(cerPrP) mice vs. deer, although other 
studies in our laboratory have demonstrated PrP
C
 in many peripheral tissues of 
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Tg(cerPrP) mice (Seelig, DM, Mason, GL, Telling, GC, Hoover, EA, unpublished 
results).  Additionally, over-fixation of our tissues could eliminate possible PrP
CWD
 
aggregates.  An alternative explanation would be that TSE induced by nasal exposure to 
CWD prions in Tg(cerPrP) mice in mediated largely by non-lymphoreticular system 
pathways.  Such pathway is supported by the recent work of Bessen and colleagues (2) 
demonstrating that intra-nasal inoculation of RML scrapie into immunodeficient 
transgenic mice transmits TSE without lymphoreticular system involvement. 
In summary, the present study demonstrates the transmissibility of prions via 
aerosolization.  Several aspects of respiratory transmission of CWD prions remain to be 
refined and no evidence of a peripheral or lymphoid phase of the infection was detected.  
The results suggest that prion exposure via the respiratory system merits consideration in 
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While the exact mechanisms of chronic wasting disease (CWD) prion 
transmission, entry, and trafficking remain incompletely elucidated, transmission by 
exposure of the oral and/or nasal mucous membranes seems certain.  As part of foraging, 
cervids commonly sustain minor lesions in the oral mucous membranes which could have 
an impact on susceptibility to prion infection.  To explore this potential co-factor, we 
studied cohorts cervid PrP transgenic mice with or without superficial abrasions to the 
lingual mucosa, to determine whether minor oral mucosa lesions may enhance 
susceptibility to CWD infection.  Accordingly, cohorts of orally inoculated mice were 
observed for signs of neurologic disease or for a maximum of 2 years.  A subset of mice 
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from each group were sacrificed at 90 days post inoculation (dpi) to assess early evidence 
of CWD transmission.  Tissues were assessed for spongiform lesions and for the CWD 
abnormal prion protein (PrP
CWD
) by western blotting and immunohistochemistry.  
Between 296 and 515 dpi, all CWD-inoculated mice with lingual lesions developed 
clinical signs of progressive neurologic dysfunction, mandating euthanasia.  Spongiform 
lesions and PrP
CWD
 were detected in the brains of all these mice.  Conversely, mice 
without oral lesions did not develop neurologic disease after 738 dpi and all were 
negative for PrP
CWD
.  No evidence of PrP
CWD
 was detected in mice of either group 
examined at 90 dpi.  The results demonstrate that minor abrasions to the lingual mucosal 
surface substantially facilitate CWD transmission, a co-factor that may be significant in 




Chronic wasting disease (CWD) is a fatal neurodegenerative prion disease 
affecting cervid species (white-tailed deer, mule deer, elk and moose).  The efficiency by 
which CWD spreads suggests transmission occurs primarily by horizontal means (21-24).  
Body fluids and excreta, including blood, saliva, urine, and feces from infected cervids, 
have been shown to contain infectious CWD prions (11, 19, 33).  While the exact 
mechanisms of CWD prion transmission, entry, and trafficking remain incompletely 
elucidated, transmission by exposure through direct or indirect contact of the oral and/or 
nasal mucous membranes seems certain.   Whether prion infection occurs after mucous 
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membrane exposure may be influenced by co-factors beyond dose, such as particle 
association with soil and status of the mucous membrane barrier (10, 15, 16, 29).  
Oral inoculation studies with sheep Scrapie and CWD have indicated that early 
amplification of protease resistant protein (Pr
PRES/Sc
) occurs within the tonsils, 
retropharyngeal lymph nodes, and/or peyers patches (5, 8, 30).  Prion dissemination can 
also occur through lymphoreticular system (LRS)-independent pathways (3, 6, 27).  The 
oral cavity is highly innervated and contact between prions and free nerve endings of the 
cranial-facial nerves might provide a direct site for prion uptake.  Foraging cervids 
experience lesions in the oral mucous membranes that could have impact on 
susceptibility to prion entry by facilitating direct contact with exposed nerves or blood 
vessels.  The present work was prompted by that of Bessen and Bartz (4, 6) who 
demonstrated in the Transmissible Mink Encephalopathy (TME) and scrapie systems that 
lesions on or injection into the tongue enhanced susceptibility to these prion infections.  
We therefore explored the hypothesis that CWD transmission may be facilitated by small 
lesions/micro-abrasions in the oral epithelial surface. 
 
MATERIAL AND METHODS 
 
Transgenic Mice and Ethics Statement:   
Transgenic mice expressing elk prion protein (Tg(CerPrP-E226)5037+/-) were 
created in the Telling laboratory (University of Kentucky).  The susceptibility of this line 
of mice to CWD infection has been described previously (1).  All animals were handled 
in strict accordance with good animal practice as defined by relevant national and/or local 
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animal welfare bodies, and all animal work was approved by Colorado State University 
Animal and Care Use Committee (ACUC approval number 08-175A-01).   
 
Monitoring and Clinical Symptoms:   
Mice were examined for evidence of neurologic abnormality every 2 days and 
weighed weekly (starting at 3 months post inoculation).  Clinical criteria for assessing 
CWD symptoms included ataxia, lethargy, tail rigidity, poor coat quality, and weight 
loss.  Upon onset of clinical symptoms, mice were isolated into individual cages to 
prevent cannibalism from cage mates.  Mice were euthanized when distinct signs of 
neurologic disease were evident.  CWD and sham-inoculated mice were housed in 
separate rooms to minimize potential for cross contamination.    
 
Inoculum and Inoculation Routes:   
The CWD inoculum consisted of brain homogenate from a CWD-infected white-
tailed deer (#104) and negative control brain homogenate from a CWD-naive white-tailed 
deer brain (#123).  Brain homogenates were prepared in 1X phosphate-buffered saline 
(PBS) to a final concentration of 10% weight to volume (w/v).  
Two cohorts of (Tg(CerPrP-E226)5037+/-) mice (n=12 CWD and n=12 control) 
were inoculated per os (PO) by direct pipet instillation of 10 µL of the 10% (w/v) brain 
homogenate onto the lingual surface of each mouse.  Two additional cohorts of 
(Tg(CerPrP-E226)5037+/-) mice (n=12 CWD and n=12 sham) were anesthetized using a 
ketamine/xylazine mix and 3 minor abrasions were created by lightly scratching the 
lingual surface using a 27-gauge needle.  Mice were then inoculated PO by pipet 
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instillation of 10 µL of inoculum onto the surface of the tongue including those regions 
containing abrasions.  Three mice from each cohort were sacrificed at 90 days post 
inoculation and analyzed for early PrP
cwd
 detection.  The remaining mice (9/cohort) were 
monitored either until clinical symptoms became apparent or to study termination at 738 
days.   
 
Western Blotting:   
Harvested tissues were prepared at 10% (w/v) in a 1X PBS/1% Triton-X 100 
mixture.  Glass beads (2.5mm, Biospec) were added to each tube and samples subjected 
to one Fastprep™ (Biosavant) cycle for 45 seconds at a speed setting of 5.5, followed by 
a 2 minute cool down at -20º.  Samples were then centrifuged at room temperature for 5 
minutes in a Microfuge
®
 18 (Beckman Coulter - F241.5P Microfuge Fixed-Angle 
Polypropylene Rotor) at 2000 rpm to remove tissue debris and supernatants stored at -20º 
until further use.   
Samples were incubated with 50 mg/µL of Proteinase K (Invitrogen) for 30 
minutes at 37º, shaking at 1000 rpm (Eppendorf Thermomixer R).  Samples were then 
combined with a reducing agent/sample buffer (Invitrogen) to a final concentration of 1X 
and electrophoresced through NuPage 12% Bis-Tris gels (Invitrogen) for 1.5 hours at 125 
volts.  Proteins were then transferred to 0.22µm PVDF membranes (Millipore) over 1.0 
hour at a setting of 125 volts.  Membranes were processed through the actively driven 
SNAP i.d. system (Millipore).  Briefly, membranes were blocked in a 0.5% casein/TBS 
(Thermo Scientific) + 0.1% tween-20 (Sigma) mixture for 3 minutes, incubated with 
monoclonal antibody BAR-224 (Spi-Bio) conjugated with HRP at a 1:20,000 dilution in 
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0.5% casein/TBS + 0.1% tween-20 for 7 minutes, and finally washed 3 times with 1X 
tris-buffered saline (TBS) + 0.02% tween-20.  Membranes were developed with ECL 
Plus Western Blotting Detection kit (GE).  Blots were viewed and photographed with a 
Gel Doc system (Fujipics). 
   
Immunohistochemistry:   
Tissues were fixed in 10% formalin for 2-to-5 days, transferred to 60% ethanol, 
embedded in paraffin, and sectioned at 5µm for staining.  Slides were de-paraffinized 
through a series of xylene/ethanol baths, treated in 89% formic acid for 15 minutes, 
rinsed in running water for 5 minutes, and then subjected to a 15 minute, antigen-retrieval 
process (Pickcell laboratories, Netherlands).  All tissues were stained by hand using a 
Tyramide Signal Amplification (TSA) Plus DNP-HRP kit (Perkin Elmer).  Briefly, slides 
were blocked with 3% H2O2 in methanol (45 minutes), blocked with either TNB buffer or 
a mouse-on-mouse (M.O.M™) IgG blocking reagent (Vector Laboratories) (45 minutes) 
with a secondary M.O.M™ protein concentrate block (5 minutes), incubated with a 1:500 
dilution of HRP-conjugated BAR-224 in TNB or the M.O.M™ protein concentrate (90 
minutes), amplified with a 1:50 dilution of 1X DNP amplification reagent in 
amplification diluent (15 minutes), enhanced with a 1:100 dilution of α-DNP-HRP in 
TNB (30 minutes), developed with chromagen AEC (30 minutes), and counterstained 
with hematoxylin (5 minutes) and bluing reagent (1 minute).  Brain sections stained by 
H&E and IHC were assessed for TSE lesions which included primary neuronal loss, 






Oral exposure of Tg(CerPrP-E226)5037+/- mice without lingual mucosal abrasions:   
Of the cohort (n=9) of CWD-inoculated (Tg(CerPrP-E226)5037+/-) mice that did 
not receive lingual lesions, 2 were euthanized at 568 and 673 dpi due to neoplasias 
unrelated to CWD, as both were negative for PrP
CWD
 by western blot and immunohisto-
chemistry; the remaining 7 mice survived until study termination at >700 dpi (Fig. 1).   
 
              Survival of Tg(CerPrP-E226) Mice Inoculated with CWD

































None of the inoculated mice exhibited clinical signs of CWD infection.  Likewise, none 
of the mice without lingual lesions orally administered negative control-inoculum 
developed signs of TSE, although 3 were euthanized between 507 and 598 dpi due to 
Fig. 1.  Kaplan-Meier survival plot of Tg(CerPrP-E226) mice with (solid square) vs. without 
(solid diamond) lingual abrasions inoculated orally with CWD.  (*) denotes mice that died of 
causes unrelated to CWD.  
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neoplasias unrelated to CWD.  Western blot (WB) analysis on brains from both early and 
terminal CWD and sham-inoculated mice were negative for PrP
CWD 
(data not shown).  
Despite application of the sensitive Tryamide Signal Amplification (TSA) 
immunohistochemistry (IHC) methodology, no PrP
CWD
 could be demonstrated in the 
brain, tongue, salivary glands, trachea, esophagus, spleen, stomach or gastrointestinal 
tract in either the early sacrificed or terminal mice (data not shown).  A summary of these 














CWD + brain 9/9 (100%) 385 ± 62 100% Lingual 
abrasions CWD - brain 0/9  (0%) 388 ± 61
c 
0% 
     
CWD + brain 0/9  (0%) 708 ± 57 0% No Lingual 




a = No. affected/total (%) 
b = Positive by western blot and immunohistochemistry 
c = One control mouse was sacrificed when each symptomatic mouse was euthanized 
 
 
Oral exposure of Tg(CerPrP-E226)5037+/- mice with lingual abrasions:   
Nine of 9 CWD-inoculated mice with lingual abrasions developed clinical 
symptoms consistent with TSE between 296 and 515 dpi and were euthanized (Fig. 1).  
None of the negative control-inoculated mice (n=9) displayed evidence of TSE 




 was demonstrated in the brain of all 9 CWD-inoculated mice by WB (Fig. 
2; lanes 3-11).  All negative control-inoculated mice were negative for PrP
CWD
 (Fig. 2; 
lane 2).  IHC confirmed the presence of PrP
CWD
 aggregates in the brain tissue of all 9 
CWD-inoculated mice, with predominant staining occurring within the obex and 
cerebellum (Fig. 3A).  Both H&E and stained IHC sections contained evidence of 
neuronal loss and gliosis consistent with CWD infection (data not shown).  All negative 
control-inoculated mice were negative for PrP
CWD
 (Fig. 3B) and TSE lesions.  TSA IHC 
analysis on peripheral tissues was again unable to detect PrP
CWD
.  A summary of these 
results can be found in Table 1. 
 
 
Fig. 2. Western blot detection of PrP
CWD
 (lanes 3-11) in brains of Tg(CerPrP-
E226)5037+/- mice with lingual lesions exposed to CWD prions.  Lesioned mice exposed 











 Lane:     1     2      3     4     5     6     7     8     9    10   11 
Inoc:      -      -      +     +     +     +     +     +     +     +     +    










Fig. 3. Immunohistochemistry (IHC) from the obex region of the medulla of: (A) a 
Tg(CerPrP-E226)5037+/- mouse with lingual lesions (20X) demonstrating aggregates of 
PrP
CWD










 Transmission of CWD prions to deer by oral inoculation has been well 
demonstrated and the oral route is considered the most plausible site of access in nature 
(8, 12, 18, 19, 23, 30).  In addition, cervids naturally acquire minor oral lesions as part of 
foraging, providing a potential cofactor for prion entry that might help explain the facile 
transmission of CWD (3, 31).  The present study models this natural event in cervidized 
transgenic mice [Tg(CerPrP-E226)5037+/- mice].  Available evidence indicates that 
cervidized transgenic mice are much less susceptible to oral CWD infection than are 
cervids, and thereby require a potent inoculum to induce infection with lower attack rates 
(28), (35).  Here we show that this resistance is negated by the presence of minor 
breeches in the lingual epithelium--enhancing CWD infection from 0 to 100%.  In 
addition, the lack of demonstrable PrP
CWD
 in non-neural tissues of the affected mice 
suggests that transit to the brain occurred by a lymphoreticular system (LRS)-
independent pathway. 
 Twenty five years ago Gajdusek (9) suggested that lesions in the conjunctiva, 
skin, or mucosal injury might facilitate the passage of Kuru.  Support of this hypothesis 
has accrued.  Scarification of either skin or gingival tissues has been shown to enhance 
the transmission of scrapie (7, 10, 14, 34).   Likewise, scarification of the lingual surface 
in hamsters exposed to scrapie or TME produced a significantly increased attack rates, 
shortened survival periods, and facilitated infection with substantially smaller prion doses 
compared with conventional per os inoculation (4, 6, 13).   The present study suggests 
that enhancement of CWD infection is even greater. 
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We surmise that mucosal lesions may have made possible direct neural contact as 
the tongue is heavily innervated (4, 36).  However, we were not able to detect PrP
CWD
 
immunostaining in any histologic structure in the tongue or lymphoid tissues at 90 days 
pi or in terminally affected mice.  In that CWD is a lymphotropic TSE (8, 30, 32), the 
lack of discernible PrP
CWD
 in LRS tissues suggests that prion ascension to the brain 
occurred independent of the LRS.  Of course caveats to this conclusion include that small 
PrP
CWD
 aggregates in peripheral tissues might have been below the sensitivity limits of 
TSA IHC protocols or that such aggregates exist in a formalin- or protease- sensitive 
form.  Nevertheless, while entry via a lymphatic or hematogenous route cannot be 
excluded, the most plausible pathway would seem to be trafficking along lingual and 
facial nerves—a prion phenomenon well demonstrated by the work of several 
investigators (4, 14, 25).    
Dose dependency in prion infections has been extensively demonstrated (2, 17, 
20, 26, 28).  While environmental contamination almost surely plays a role in CWD 
transmission, available information indicates that prion concentrations in excretions, soil, 
and the environment are below the detection limits of conventional assays (11).  Results 
of the present study may help explain how exposure to low concentrations of prions in 
urine, feces, and soil (11, 19, 33) may be able to transit the mucosal barrier to initiate 
infection in foraging cervids, other ruminants, and perhaps in other species.  
In summary, superficial lesions to the lingual surface of cervid transgenic mice 
significantly enhanced susceptibility to oral CWD infection.  The absence of PrP
CWD
 
detection in the tongue, lymphoid tissues, or any peripheral tissue site suggested a direct 
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neural route of invasion.  These results implicate one co-factor that could facilitate CWD 
infection in cervids after oral exposure to very low concentrations of prions in nature.  
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Chronic wasting disease is horizontally transmitted, most assuredly with 
involvement of oral and nasal mucosa as the obvious first contact site for infectious 
prions.  Cervids continually monitor their environment by exposing highly-sensitive 
olfactory epithelium and/or the vomeronasal organ to particulates drawn in via inhalation 
and the Flehmen response.  Moreover, cervids commonly acquire minor lesions on oral 
mucous membranes when foraging.  Exposing prions to nasal passages or compromised 
oral mucosa has proven exceedingly effective at transmitting disease; however where the 
initial site of prion uptake within mucous membranes occurs remains unknown.  To 
address this question, two lines of FVB mice trangenetically expressing the cervid prion 
protein [Tg(CerPrP)1536 and Tg(CerPrP-E226)5037 +/-] and a prion protein knockout 
mouse [FVB PrP
0/0
] were exposed via aerosol, nasal and oral routes to CWD prions.  
Cohorts of mice were serially sacrificed up to 4 hours post inoculation.  Respective 
tissues based on route of inoculation were assessed for PrP
CWD
 by tryamide signal 
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amplification immuno-histochemistry.  Detection of PrP
CWD
 was largely inconclusive as 
immunoreactive staining appeared in both CWD and sham-inoculated cohorts and 
Tg(CerPrP) and PrP
0/0
 mice, all irrespective of sacrifice times.  These results demonstrate 




 Transmissible Spongiform Encephalopathies (TSE’s), or prion diseases, are 
neurodegenerative disorders that affect humans and a variety of animal species with an 
inevitably fatal outcome.  TSE’s are believed to be transmitted via a horizontal route (24, 
25), due to the lack of evidence supporting sustainable maternal transmission.  The oral 
and nasal mucosas have been implicated as the primary site of contact for infectious 
prions.  While the transmission of Kuru (15), transmissible mink encephalopathy (TME) 
(17), bovine spongiform encephalopathy (BSE) (32), and new-variant Creutzfeldt-Jakob 
disease (nvCJD) (8, 33) have been shown to occur primarily through oral ingestion, the 
exact mechanism for scrapie and chronic wasting disease (CWD) transmission remains 
unknown.   
CWD, as well as other TSE’s are lymphotropic.  Studies tracking infectious 
prions after oral and nasal inoculations confirmed accumulation first within the tonsil, 
retropharyngeal lymph node, and gut associated lymphoid tissue (GALT) (3, 5-7, 14, 20, 
21, 29, 30), therby indicating that lymphatic amplification preceded neural invasion and 
disease onset.  Proposed mechanisms involving platelets, B cells, dendritic cells, and 
macrophages that might mediate the trafficking of prions to lymphatic structures have 
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been explored, yet the exact mechanism has not been elucidated (1, 22, 28).  
Interestingly, while these studies provided valuable information about trafficking and 
early lymphoid pathogenesis, events earlier than one week post inoculation in oral or 
nasal prion infections have not been examined.     
 How prions transit the mucosal barrier is of considerable importance in 
understanding prion pathogenesis.  Previous studies have demonstrated that exposing 
prions to nasal passages or compromised oral mucosa enhanced prion infection and 
required a smaller dose to induce TSE diseases compared to conventional routes (5, 13, 
19) (Denkers ND, Telling, GC, Hoover EA, unpublished results).   Here we extend those 
studies by focusing on the first hours after prion exposure to the mucous membranes in of 
cervidized transgenic [Tg(CerPrP)] and prion protein knockout [FVB PrP
0/0
] mice with 
the goal of identifying sites of CWD prion uptake.      
 
MATERIAL AND METHODS 
 
 
Transgenic Mice and Ethics Statement:   
Two lines of transgenic mice created in the laboratory of Dr. Glenn Telling 
(University of Kentucky) were used for these studies: Both lines express the cervid PrP 
gene [Tg(CerPrP)1536+/-] and [Tg(CerPrP-E226)5037+/-] on a FVB mouse background.  
The PrP knockout mouse, in which the expression of mouse prion gene had been deleted 
[FVB PrP
0/0
] were generated from heterozygous 5037 mice in the Zabel laboratory (Dr. 
Mark Zabel, Colorado State University).  The susceptibility of these mice to CWD 
infection or lack thereof after intracerebral inoculation has been previously described (2, 




 gene insert was performed by PCR.  All mice were 5 to 12 weeks of age at 
time of inoculation.  All animals were handled in strict accordance with good animal 
practice as defined by relevant national and/or local animal welfare bodies, and all animal 
work was approved by Colorado State University Animal and Care Use Committee 
(ACUC approval number 08-175A-01).   
 
Inoculum:   
The CWD inoculum consisted of brain homogenate from a CWD-infected white-
tailed deer (#104) and sham-control brain homogenate from a CWD-naive white-tailed 
deer brain (#123), both of which were infected at Colorado State University.  Brain 
homogenates were prepared in 1X phosphate-buffered saline (PBS) to a final 
concentration of 10% weight to volume (w/v) for PO and IN inoculations and a 5% (w/v) 
for aerosol exposure.  
 
Oral (PO) Inoculation:   
Two cohorts of Tg(CerPrP-E226)5037+/- and FVB PrP
0/0
 mice (n=9 CWD and 
n=9 sham for each line) were used in these experiments.  Mice were anesthetized using a 
ketamine/xylazine mix and 3 minor abrasions were created by lightly scratching the 
lingual surface using a 27-gauge needle.  Mice were then inoculated by direct pipet 
instillation of 10 µL of the 10% (w/v) homogenate onto the surface of the tongue 
including the regions containing abrasions.  Mice (n=3/cohort) were sacrificed 
immediately (T=0), 1 hour post inoculation (T=1), and 4 hours post inoculation (T=4) 
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and all tissues were immersion fixed in Paraformaldehyde/ Lysine/Periodate (PLP) for 24 
hours.  
 
Intranasal (IN) Inoculation: 
Two cohorts of (n=9 CWD and n=9 sham for each line) were used in these 
experiments.  Mice were inoculated with 10 µL (5 µL per nostril) of the 10% (w/v) 
extracts by direct pipet instillation into the nasal passages.  Mice (n=3/cohort) were 
sacrificed immediately (T=0), 1 hour post inoculation (T=1), and 4 hours post inoculation 
(T=4).  Tg(CerPrP-E226)5037+/- mouse tissues were immersion fixed in 10% formalin 
for 4 days, Tg(CerPrP)1536+/- mouse tissues were immersion fixed in PLP for 24 hours, 
and two sets of FVB PrP
0/0
 mouse tissues were fixed in both 10% formalin for 4 days and 
PLP for 24 hours.   
 
Aerosol Inoculation:   
Two cohorts of Tg(CerPrP-E226)5037+/- and FVB PrP
0/0
 mice (n=9 CWD and 
n=9 sham for each line) were used in these experiments.  Mice were anesthetized using a 
ketamine/xylazine mixture, placed in a custom designed chamber as previously described 
(13), providing nose-only exposure then subjected to aerosolized 5% (w/v) brain 
homogenate for 4-minutes.  All aerosol exposed mice were administered 0.01 mL of 
epinephrine intraperitoneally immediately post inoculation to stimulate the Flehmen 
response. Mice (n=3/cohort) were sacrificed immediately (T=0), 1 hour post inoculation 
(T=1), and 4 hours post inoculation (T=4).  Tg(CerPrP-E226)5037+/- and FVB PrP
0/0
 
mouse tissues were immersion fixed in 10% formalin for 4 days.   
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Immunohistochemistry:   
Post fixation, tissues were transferred to 60% ethanol.  Trimmed in tissue was 
subjected to a 5 minute formic acid (89%) treatment, thoroughly washed in water, 
embedded in paraffin, and sectioned at 5µm for staining.  Slides were de-paraffinized 
through a series of xylene/ethanol baths, treated in 89% formic acid for 5-45 minutes, 
rinsed in running water for 5 minutes, and then subjected to a 15 minute, antigen-retrieval 
process (Pickcell laboratories, Netherlands).  All tissues were stained by hand using a 
Tyramide Signal Amplification (TSA) Plus DNP-HRP kit (Perkin Elmer).  Briefly, slides 
were blocked with 3% H2O2 in methanol (60 min), blocked with either TNB buffer or a 
mouse-on-mouse (M.O.M’s™) IgG blocking reagent (Vector Laboratories) (60 min) with 
a secondary M.O.M.™ protein concentrate block (5 minutes), incubated with a 1:500 
dilution of HRP-conjugated BAR-224 in TNB or the M.O.M.™ protein concentrate (90 
minutes), amplified with a 1:50 dilution of 1X DNP amplification reagent in 
amplification dilulent (15 minutes), enhanced with a 1:100 dilution of α-DNP-HRP in 
TNB (30 minutes), developed with chromagen AEC (30 minutes), and counterstained 
with hematoxylin (5 minutes) and bluing reagent (1 minute).  A minimum of 5 sections 











Orally inoculated Tg(CerPrP-E226)5037+/- mice: 
Tissues analyzed included the tongue, salivary gland, submandibular lymph node 
(if present), esophagus, trachea, stomach, small intestine, and spleen.  No PrP
CWD
-
specific staining was detected in any tissue at any of the time points examined.  
Immunoreactivity was observed in both sham and prion-inoculated Tg(cerPrP) mice 
within the circumvallate papillae of the tongue and in the myenteric plexuses of the 
stomach and small intestine.  This staining was attributed to incomplete removal of PrP
C
.  
Staining was also present in mast cells of the tongue in both cohorts, irrespective of 
formic acid treatment times. 
 
Orally inoculated FVB PrP
0/0
 mice:   
Tissues analyzed included the tongue, salivary gland, submandibular lymph node 
(if present), esophagus, trachea, stomach, small intestine, and spleen. No PrP
CWD
-specific 
staining was detected in any tissue at any of the time points examined.  In these mice, as 
might be expected, no immunoreactivity was observed in the circum vallate papillae or 
myenteric plexus but was present in mast cells (as seen previously) in both cohorts, 
irrespective of formic acid treatment times. 
 
Intranasally inoculated Tg(CerPrP-E226)5037+/- and Tg(CerPrP)1536+/- mice: 
Tissues analyzed included the nasal cavity containing the vomeronasal organ 
(VNO), nasal associated lymphoid tissue (NALT), respiratory and olfactory epithelium, 
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the olfactory bulb and the accessory olfactory bulb (AOB) when present.  Additionally, 
the trachea, esophagus, lung, and spleen were assessed. No PrP
RES
-specific staining was 
detected in any tissue at any of the time points examined.  In both sham and prion-
inoculated Tg(cerPrP) mice, immunoreactivity was present in the glomeruli of the 
olfactory bulb, the olfactory nerves below the olfactory epithelium, and the ventral-
medial aspect of the nasal septum just below the respiratory epithelium.  This staining 
was therefore considered to represent incompletely quenched PrP
C
 immunoreactivity in 
these high PrP
C
-containing tissue sites.   In neither the NALT nor the VNO was 
immunoreactivity detected.  
 
Intranasally inoculated FVB PrP
0/0
 mice:   
Tissues analyzed included the nasal cavity containing the vomeronasal organ 
(VNO), nasal associated lymphoid tissue (NALT), respiratory and olfactory epithelium, 
the olfactory bulb and the accessory olfactory bulb when present.  As expected, no 
PrP
RES
-specific staining was detected in any tissue at any of the time points examined.  
Immunoreactive staining was detected in ventral-medial aspect of the nasal septum just 
below the respiratory epithelium, similar to observations in the Tg(CerPrP-E226)5037+/- 
and  Tg(CerPrP)1536+/- mice.   
 
Aerosol inoculated Tg(CerPrP-E226)5037+/- mice:   
Awaiting results: Oct./Nov. 2010 
Aerosol inoculated FVB PrP
0/0
 mice:   





 The transmission of CWD to cervids and transgenic mice expressing the cervid 
prion protein through oral and nasal inoculations has been demonstrated (13, 14, 20, 23, 
27, 29, 31) and likely represents the most natural routes for prion acquisition.  In addition 
to these studies, work involving scrapie, TME, and CWD have provided substantial 
evidence that the oral and nasal route are much more efficient (require a considerably 
lower infectious prion dose) at transmitting disease, especially if the mucosal surface is 
compromised (4, 5, 7, 12, 18, 19) (Denkers ND, Telling GC, Hoover, EA unpublished 
results).  The present studies were undertaken in an attempt to localize CWD prions at 
sites within the oral and nasal mucosa at the earliest possible times (T=0, 1, 4 hours pi) 
using [Tg(CerPrP)1536+/-], [Tg(CerPrP-E226)5037+/-] and PrP knockout [FVB PrP
0/0
] 
mice.  The results of these experiments were inconclusive in that any immunoreactivity 
detected was present in both CWD and sham-inoculated mice for all cohorts, at all time 
points, and attributable to incomplete removal of PrP
C
 in high expression sites such as 
taste and olfactory structures. 
 Both lines of transgenic mice used in this study have been shown to over-express 
the cervid prion protein (~ 5x more) in the CNS, with the Tg(CerPrP-E226)5037+/- line 
providing greater peripheral expression.  Due to the overabundance of prion protein, 
abrogating PrP
C
 might require more stringent applications of formic acid.  We addressed 
this issue by varying the exposure times the slides were in formic acid from 5 to 45 
minutes.  This was problematic, as PrP
CWD
 is degraded by formic acid.  With such small 
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inoculation doses, we ran the risk of destroying our initial inoculum.  Inoculum amount 
proved inconsequential, as increased formic acid times were insufficient at removing the 
immunoreactivity seen in the glomeruli of the olfactory bulb, the circum vallate papillae, 
and the myenteric plexi of the small intestine.  Supporting evidence that the 
immunoreactivity seen in the above tissues was PrP
c
 came from the FVB PrP
0/0
 mice that 
were negative for staining in all these tissues.  An ongoing experimental approach to try 
and correct this problem includes a formic acid treatment after the antigen retrieval 
process. 
 Limited studies have previously attempted to detect PrP
RES
 immediately after 
inoculation.  These experiments exposed sheep to scrapie(16) and mice to Creutzfeldt-
Jakob disease (26) via the intracranial route, then analyzed brain sections for PrP
RES
 one 
and five hours post-inoculation, respectively.  Surprisingly, dissemination of the original 
inoculum was rapid, leading to limited or no detection of PrP
RES
 in both studies.  These 
findings in part explain our inability to detect PrP
CWD
 as detecting inoculum distributed 
over a mucosal surface is more challenging.  
 Another potential cause of the non-specific immunoreactivity could have come 
from the fixative we used.  Cohorts of mice were originally fixed in 10% formalin buffer 
for 4 days.  Following experimental initiation, information was presented that over-
fixation with formalin could lead to decreased sensitivity for PrP
res
 and that PLP was 
potentially better (9, 11), although no direct comparative study was done.  None the less, 
a second cohort of mice were inoculated, sacrificed, and fixed using PLP (immersed for 
24 hour).  Comparative immunohistochemistry’s (IHC) were performed between 
formalin and PLP fixed tissues, to which no discernable difference could be made due to 
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the inability to eliminate PrP
C
 staining from either transgenic mouse line (irrespective of 
time spent in formic acid).  There was no change in ability to detect PrP
CWD
 in the FVB 
PrP
0/0 
mouse line based on fixation method.  Further evaluation is required to optimize 
the fixation of tissue in order to detect prions in early inoculation experiments.   
The most perplexing staining of these experiments was located in the mast-like 
cells of the tongue and the ventral-medial aspect of the nasal septum.  Immunoreactivity 
in these two areas was almost uniform in both CWD and sham-inoculated cohorts of all 
three transgenic mouse lines, regardless of fixative used.  One explanation for these 
results was that staining was caused by an immunological response to inoculum placed in 
nasal passages and the trauma of lingual abrasions.  Steps taken to eliminate this staining 
included varying treatment times of the hydrogen peroxide and/or blocking reagents to 
quench any endogenous peroxidases.  These treatments were ineffective.  We are 
currently investigating the use of R505 and unconjugated-BAR to alleviate this possible 
cross-reactive staining.   
  In summary, we were not able to locate early entry sites for prion invasion in the 
oral and nasal mucosa.  This result is unfortunately consistent with the limited, available 
published references indicating that very early, post infection in situ demonstration of 
protease-resistant prion protein is problematic, a circumstance compounded when 
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CONCLUSIONS AND FUTURE DIRECTIONS 
 
 This work has demonstrated that; 1) CWD can be transmitted via the respiratory 
route through direct nasal contact; 2) aerosolized prions appear to be more efficacious 
when inhaled vs. direct contact to the nasal mucosa passages; 3) lesions to the oral 
mucosa greatly facilitate the transmission of CWD; 4) detecting prions in mucosal 
surfaces immediately after exposure requires more sensitive methodology than that 
employed here.   
These findings in Tg(CerPrP) mice suggest that the respiratory system could be a 
natural transmission route of CWD in cervids.  Exposure to inhaled prions could provide 
immediate access to free-nerve endings in the olfactory or VNO epithelium, or to 
lymphoid structures such as the retropharyngeal lymph node or nasal associated 
lymphoid tissue.  Moreover, the finding that CWD can be transmitted by aerosolization is 
novel and implies that direct contact between animals is not necessary to transmit disease, 
albeit prions could still be inhaled from contaminated environment sources or from nasal 
contact with infected animals.   
The efficiency by which aerosolized CWD was transmitted suggests that smaller, 
more infectious particles were created during the process and that the host could process 
these smaller particles easier through mucosal or lymphoid surfaces.  This finding has 
implication for the transmission of other prion diseases as well as the need to reevaluate 
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prion biosafety protocols.  Protocol changes would primarily be applicable to prion 
material known to infect humans and might include; 1) that all manipulations are done in 
biosafety cabinets or physical containment devices; and 2) the use of full face respirators 
instead of masks, goggles, and face shields.      
This work is highly relevant to the probability of nasal and/or aerosol 
transmission of CWD in nature.  Throughout fall, deer, elk, and moose participate in 
breeding rituals known as the rut.  During this time, males and females frequently urinate 
to mark territory or assert reproductive status (5, 9, 12).  The Flehmen response is 
performed by both genders to decipher these chemosensory cues.  By nuzzling, sniffing, 
and licking urine as it is voided and/or sampling voided urine on the ground (3), the 
respiratory mucosa are being exposed to urine and soil particulates by direct nasal contact 
as well as by aerosolization.  Considering CWD prions remain infectious in urine and soil 
(6, 8), it is possible that rutting behaviors provide a plausible mechanism for natural 
CWD transmission and should be investigated further.    
Future directions of this work might involve brain homogenate titration 
experiments to determine a minimum infectious dose required for respiratory route 
exposure.  Determining the efficacy of nasal mucosal exposure could better explain the 
relationship between prion dose in the environment and the ease in which CWD is 
transmitted.  To mimic possible natural infections, directly inoculating or aerosolizing 
urine and saliva might demonstrate the capability of excreta to transmit disease.  
Additionally, if prions remain infectious in the soil for years, aerosolizing lyophilized 
urine and saliva or urine and saliva dried on soil, might help determine if environmental 
factors facilitate transmission.   
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We found that small abrasions to the lingual surface of Tg(CerPrP) mice 
significantly enhanced the transmission rate of CWD.  This work expands upon the 
precedent set by Bartz, Bessen, and others (1, 7) showing lingual inoculations transmitted 
disease with greater efficiency than standard oral inoculations.  Oral lesions could allow 
ingested prions to enter directly into the circulatory, lymphatic, or nervous system.  Lack 
of involvement of the lymphoreticular system in our model implies entry most likely 
occurred through exposed free nerve endings.   
Our results may directly contribute to the understanding of natural oral 
transmission of CWD, in that cervids that experience mucosal abrasions, possibly due to 
tooth eruption, harsh forage, or disease, may be more susceptible to CWD infections.  
Gingival tissues in deer are constantly disrupted in the first 24 months of life by tooth 
eruptions (10).  Gingival inoculations studies with scrapie demonstrated higher attack 
rates than the conventional oral route (2); therefore it is plausible that CWD might be 
transmitted via the dental route in nature.  
Oral cavity foreign bodies (presumed to be lodged forage) have been documented 
in cervids at time of necropsy (11).  Penetration of contaminated feed or open wounds 
caused from foraging could allow trans-mucosal entry and CWD transmission.  
Moreover, assumptions that primary infections from an ancillary disease, such as 
epizootic hemorrhagic disease (EHD), could facilitate CWD transmission are reasonable.  
Acute and chronic clinical presentation of EHD includes lesions/ulcers to the tongue and 
dental pad (4).  The previous observations that oral lesions occur naturally validates our 
claim that CWD could be transmitted through abraded mucosal surfaces. 
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Future directions of this work might again involve titration experiments to 
determine a minimum infectious dose.  Once more, this might help clarify the 
relationship between environmental prion dose and CWD transmission.  The use of urine, 
saliva, soil, and feces to mimic a natural exposure might expand our knowledge on the 
ability of excreta to transmit disease.  Investigating the length of time between the initial 
lesion and prion exposure required to establish sufficient disease transmission could 
provide a time frame of susceptibility.    
 We found our capacity to detect PrP
CWD
 in Tg(CerPrP) mice immediately after 
inoculation suboptimal.  The quick dissemination of infectious prions immediately after 
exposure combined with our inability to eliminate PrP
C
 indicates that further adjustments 
in tissue and slide processing are required.  The benefit of this work, if successfully 
optimized, would greatly enhance our understanding of initial prion pathogenesis.  Co-
localizing the infectious prions to specific cell types could elucidate how trans-mucosal 
entry occurs, whether immune cells are involved initially or are secondary carriers, and in 
a broader spectrum, which systems (circulation, lymphatic, nervous) are involved in 
initial uptake.   
Future directions of this work might or currently include; 1) altering fixation time 
or method of fixation (perfusion vs. immersion); 2) varying hydrated-autoclaving and 
formic acid treatment procedures; 3) using different prion PrP antibodies to eliminate 
cross-reactivity; 4) employing alternate detection methods (immunofluorescence); and 5) 
utilizing purified, pre-labeled prions rods for tracking studies. 
A limitation of these studies involves the use of cervidized-transgenic mice 
instead of a cervid species.  While transgenic mice allow for easy experimental 
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manipulations, anatomical and physiological differences between mice and cervids make 
correlations for disease transmission and pathogenesis difficult to assess.  An additional 
limitation of these studies includes the use of brain material as inoculum instead of 
naturally excreted material.  While the largest concentration of infectious prions resides 
within the CNS and lymphoid structures, accessibility to this material in nature is limited 
compared to the constant secretion of prions in ‘secreta’.   
In summary, the results presented in this dissertation suggest new paradigms for 
how CWD is naturally acquired.  We demonstrated that the respiratory route (through 
direct nasal contact) is a viable site for CWD transmission, with a significant increase in 
efficacy if exposed via aerosolization.  In addition, we demonstrated that lingual lesions 
greatly facilitated the transmission of CWD.  Finally, we established that more sensitive 
methods might be required to detect prions immediately after inoculation.  Continuing to 
build on this foundation should further elucidate transmission and early pathogenesis 
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